Aimmune Therapeutics ^Investors

Aimmune Therapeutics is a biotechnology company based in Brisbane, California, United States, founded in 2011 The company specializes in developing treatments for food allergies, leveraging innovative immunotherapy approaches Aimmune has successfully raised approximately $160 million in funding to advance its research and product development initiatives The organization is dedicated to improving the quality of life for individuals with food allergies through its groundbreaking therapies Aimmunes commitment to scientific excellence and patient safety positions it as a leader in the field of allergy treatment